Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigator Initiated Double Blind Randomized Study of Alefacept Treatment Prevention of Graft Versus Host Disease in Myeloablative Stem Cell Transplantation

NCT00361413 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00361413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00361413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigator Initiated Double Blind Randomized Study of Alefacept Treatment Prevention of Graft Versus Host Disease in Myeloablative Stem Cell Transplantation
Lead sponsor
Hadassah Medical Organization
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2006
Completion date
December 31, 2013
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease